Kerrisdale Advisers’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,580
Closed -$2.5M 98
2024
Q3
$2.5M Buy
30,580
+13,210
+76% +$1.15M 0.85% 33
2024
Q2
$1.85M Buy
17,370
+1,850
+12% +$177K 0.58% 44
2024
Q1
$1.51M Sell
15,520
-54,300
-78% -$4.78M 0.47% 50
2023
Q4
$5.47M Sell
69,820
-1,640
-2% -$112K 1.63% 25
2023
Q3
$4.48M Sell
71,460
-24,080
-25% -$1.58M 1.42% 23
2023
Q2
$6.14M Sell
95,540
-44,530
-32% -$2.51M 1.66% 20
2023
Q1
$7.43M Sell
140,070
-50,010
-26% -$2.45M 2.2% 12
2022
Q4
$7.99M Sell
190,080
-511,150
-73% -$21.4M 2.37% 12
2022
Q3
$25.7M Buy
701,230
+633,700
+938% +$28.2M 6.23% 2
2022
Q2
$2.88M Buy
+67,530
New +$3.21M 0.91% 37

Other funds holding LRCX

Kerrisdale Advisers's LRCX Position: Q4 2024 in Review

Kerrisdale Advisers sold out of Lam Research (LRCX) in Q4 2024, closing a stake of 30,580 shares — an estimated $2.5M sold.

Kerrisdale Advisers first reported a position in LRCX in Q2 2022 and held it in 10 quarters. The position peaked at $25.7M in Q3 2022. 1,690 funds tracked by Wall St. Rank hold LRCX as of Q4 2024.

  • Kerrisdale Advisers reported no remaining Lam Research position as of Q4 2024 after selling out during the quarter.
  • Kerrisdale Advisers sold 30,580 Lam Research shares in Q4 2024, an estimated $2.5M.
  • Kerrisdale Advisers first reported a position in Lam Research in Q2 2022 and held it in 10 quarters.
  • Kerrisdale Advisers's Lam Research position peaked at $25.7M in Q3 2022.
  • 1,690 funds tracked by Wall St. Rank held Lam Research as of Q4 2024.

Based on Kerrisdale Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.